BioSpace News Archive

Drug Development

Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks

Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks.

March 27, 2023
·
8 min read
Business

Coya Therapeutics Strengthens Leadership Team with Addition of Arun Swaminathan, Ph.D. as Chief Business Officer

Coya Therapeutics, Inc. today announced the appointment of Arun Swaminathan, Ph.D. to the role of Chief Business Officer.

March 27, 2023
·
8 min read
NeoGenomics to Host Investor Day on April 4, 2023

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that the Company will host an Investor Day on Tuesday, April 4, 2023, starting at 8:00 am ET.

March 27, 2023
·
2 min read
Drug Development

Avacta to Present Pre-Clinical Data on AVA3996 at the American Association for Cancer Research Annual Meeting

Avacta Group plc announces it will present a poster entitled ‘AVA3996, a novel pre|CISION™ medicine, targeted to the tumor microenvironment via Fibroblast Activation Protein-alpha (FAP-a) mediated cleavage’ , at the American Association for Cancer Research (AACR) 2023 Annual Meeting, taking place at Orange County Convention Center, Orlando, Florida.

March 27, 2023
·
2 min read
Business

Vaxxinity Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updates

Vaxxinity, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022.

March 27, 2023
·
10 min read
Biotech Bay

Pliant Therapeutics Announces Poster Presentations at the 2023 American Thoracic Society International Conference

Pliant Therapeutics, Inc. today announced that the Company will present three scientific posters at the upcoming 2023 American Thoracic Society (ATS) International Conference, taking place May 19-24, 2023, in Washington, DC.

March 27, 2023
·
5 min read
Drug Development

YS Biopharma’s PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study

YS Biopharma announced its positive interim Phase II safety and immunogenicity data for its PIKA recombinant COVID-19 Vaccine.

March 27, 2023
·
8 min read
Deals

Calibre Scientific Acquires SciQuip, a UK Provider of Scientific Equipment, Supplies and Services

Calibre Scientific is pleased to announce the acquisition of SciQuip Ltd, a UK based provider of scientific equipment, laboratory supplies and services to customers in the research, university, hospital and biopharma sectors.

March 27, 2023
·
2 min read
BioMidwest

Rockwell Medical to Showcase its Hemodialysis Concentrates Portfolio at DialysisTechConneXion40

Rockwell Medical, Inc., a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that it will showcase its hemodialysis concentrates portfolio at DialysisTechConneXion40.

March 27, 2023
·
3 min read
Business

BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

BioNTech SE reported financial results for the three months and full year ended December 31, 2022, and provided an update on its corporate progress.

March 27, 2023
·
32 min read